Viatris Sets November Date for Third-Quarter Financial Disclosure

Interested parties can access the live presentation through the company’s investor relations portal at investor.viatris.com. For those preferring telephone access, the firm has provided dedicated lines at 844-308-3344 for domestic participants and 412-317-1896 for international callers. A recorded version of the session will remain available on the company website following the event. The announcement marks the latest update from the global healthcare provider, which maintains a broad portfolio spanning generics, established brands, and value-added medicines across its primary hubs in the United States, China, and India.